Embryo Assessment Support
Embryo grading models analyze time-lapse or static images to propose morphology scores and rankings. The embryologist reviews each proposal and makes every selection decision independently.
Custom Software
AI Reproductive Medicine Software Development
AI reproductive medicine software applies machine learning to embryology imaging, cycle monitoring data, and outcome records to support fertility teams with embryo assessment, protocol review, and workflow automation. It functions as decision support only: the embryologist and reproductive endocrinologist make every selection and treatment decision.
Fertility care combines laboratory precision with emotionally weighted patient decisions, which raises the bar for both accuracy and transparency in software. Taction Software builds AI reproductive medicine tooling that supports embryology and clinical workflows while keeping every judgment with the clinical team. Each build is engineered for traceability, chain of custody integrity, and honest communication of uncertainty.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI Reproductive Medicine Software
AI reproductive medicine software refers to machine learning and workflow automation applied to fertility care: time-lapse embryo imaging, follicle monitoring, hormone trend analysis, cycle protocol review, and outcome tracking. Models assess morphology and morphokinetics, surface patterns across historical cycles, and automate documentation that currently consumes embryologist and nursing time. These systems are assistive by definition. They rank, flag, and organize, while the embryologist and reproductive endocrinologist retain every transfer, freeze, and protocol decision. This work sits inside our broader healthcare AI practice, where validation, subgroup reporting, and regulatory classification are engineering deliverables.
Morphokinetic Analysis
Morphokinetic analysis tracks cleavage timing and developmental events from time-lapse sequences, producing structured annotations that reduce manual observation logging for the embryology team.
Cycle Monitoring and Trends
Cycle tooling organizes follicle counts, endometrial measurements, and hormone trends into a single view, supporting protocol review conversations led by the treating physician.
Outcome Pattern Analysis
Retrospective analysis surfaces patterns across historical cycle outcomes by protocol and patient characteristic, informing clinical discussion without generating individual predictions presented as certainty.
Laboratory Workflow Automation
Embryology lab tooling automates witness logging, specimen tracking, and chain of custody documentation, reducing transcription while preserving every verification step required by protocol.
Decision Support Boundaries
Every output carries clinical decision support framing. The software does not select embryos, set protocols, or make transfer decisions in any configuration we build.
Core AI Reproductive Medicine Services
Our AI reproductive medicine services cover imaging integration, model development, laboratory workflow tooling, patient-facing systems, and reporting automation. Fertility clinics run a distinctive systems mix: incubator and time-lapse platforms, an EMR that may be fertility-specific, a cryostorage inventory, and mandatory outcome reporting. We scope each interface explicitly rather than assuming vendor access. Engagements typically open with a review of imaging platform export capability, EMR structure, and current reporting workload. Deliverables are structured so the laboratory director, physicians, practice management, and compliance can each review their portion before anything reaches live clinical or laboratory use.
01
Imaging Platform Integration
We build interfaces to time-lapse incubators and microscopy systems, normalizing embryo imaging exports into a consistent pipeline suitable for model input and long-term retention.
02
Custom Model Development
We train morphology assessment models on clinic data, documenting training provenance, holdout evaluation, and performance across patient age bands before any clinical use.
03
Fertility EMR Integration
Integration connects cycle data, orders, and results with your EMR. Our EHR and EMR integration practice covers the interface layer this depends on.
04
Cryostorage and Inventory Tracking
Cryostorage tracking systems manage tank inventory, straw location, consent status, and audit history, addressing the traceability failures that create serious liability exposure.
05
Patient Portal and Communication
Patient-facing tooling handles scheduling, medication instructions, and cycle updates. Our patient portal development work covers patient engagement boundaries, routing clinical questions to staff.
06
Reporting and Registry Automation
Structured extraction prepares outcome reporting submissions from clinical data, reducing manual abstraction while keeping staff verification a required step before filing.
Benefits of AI Reproductive Medicine Software
The benefits of AI reproductive medicine software concentrate in assessment consistency, laboratory documentation quality, and reduced administrative load on a small specialized team. Embryo grading varies between embryologists and between sessions, and structured annotation makes that variation visible and measurable. Cryostorage traceability is a recognized risk area where software materially improves auditability. We publish no pregnancy, live birth, or success rate figures of any kind, because those depend entirely on patient population and clinical practice, and claiming them would be both unsupportable and inappropriate in this field.
Assessment Consistency
Structured scoring reduces inter-embryologist variability in morphology assessment, producing annotations that compare reliably across sessions and support internal quality review.
Reduced Documentation Load
Automated witness logging and annotation capture lower laboratory documentation burden, freeing embryologist attention for procedures rather than transcription during time-critical work.
Stronger Traceability
Complete chain of custody records for every specimen movement, from retrieval through storage, support audit readiness and reduce the risk of identification errors.
Better Quality Review Data
Structured cycle and laboratory data makes quality management review measurable, supporting the internal audits your laboratory director already conducts.
Clearer Patient Communication
Consistent cycle updates and instruction delivery reduce phone volume, complementing broader patient engagement app development approaches for treatment adherence support.
Lower Administrative Overhead
Automated preparation of outcome reporting and billing data reduces manual work in practices where administrative staffing is deliberately lean.
Our AI Reproductive Medicine Process
We deliver AI reproductive medicine projects in gated phases so clinical and laboratory stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, imaging data availability, and regulatory classification, since software influencing embryo selection may carry Software as a Medical Device obligations. Development is iterative with embryologist and physician review inside each cycle. Deployment is staged: shadow mode first, where model output is logged but never shown, then limited laboratory availability. This sequencing matters because embryology models trained elsewhere frequently transfer poorly to a different laboratory’s culture conditions and imaging setup.
Discovery and Regulatory Assessment
Discovery defines intended use, evaluates imaging export capability, and assesses whether SaMD classification applies, producing a fixed-scope estimate with a documented pathway.
Data Assessment and Annotation
We evaluate imaging archives and outcome linkage, establishing annotation protocols with your embryologists, since ground truth quality constrains model performance more than architecture.
Model Development and Validation
Development runs from cross-validation to held-out validation, reporting performance across patient age bands and protocol types so limitations are documented rather than averaged away.
Laboratory Workflow Integration
Integration fits tooling to bench reality, including glove use, timing constraints, and witness requirements, because laboratory workflow friction determines whether embryologists adopt it.
Shadow Mode Evaluation
The system runs in shadow deployment, logging output alongside embryologist assessments so your laboratory measures agreement and identifies failure modes without influencing any decision.
Staged Rollout and Governance
Rollout expands with performance dashboards, laboratory quality review, and continuing post-deployment surveillance for the life of the deployment.
Technology and Compliance
Reproductive medicine software handles PHI, genetic information in some configurations, and embryology records with long retention obligations, so compliance posture is designed in from the first sprint. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where software influences embryo selection, it may meet the definition of Software as a Medical Device, which changes validation and change control obligations substantially. Fertility practices also operate under CLIA and state-specific requirements, and consent handling for stored material carries its own complexity. We assess all of this during discovery rather than retrofitting.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these baseline controls.
SaMD and FDA Considerations
Software influencing embryo selection may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation records, and change control.
Laboratory and CLIA Alignment
We build to support CLIA documentation expectations and laboratory quality management requirements, including versioned records and defined validation of any computational output.
Consent and Disposition Management
Consent management for stored embryos and gametes requires versioned records, directive tracking, and long retention. We build this as a first-class data model rather than a document store.
Validation and Bias Monitoring
Validation reports performance across patient age bands and protocol types, with continuing bias monitoring, since models trained on narrow populations transfer unpredictably.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before production release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects. We work from four US offices in Chicago, Cheyenne, Austin, and Sacramento, and hold ISO 27001 certification. Our credibility in specialty clinical software comes from delivery rather than positioning: we have built EHR and EMR platforms, FDA-registered mobile applications, and behavioral health systems, so the integration and regulatory constraints that stall fertility projects are familiar ground. Our leadership brings more than 20 years of personal experience in the field, which shapes how we scope regulated clinical work.
01
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing practical depth in clinical workflow and laboratory systems integration.
02
Regulated Product Experience
We delivered the FDA-registered applications Revive Ease and PainKare, so design controls, validation documentation, and change management are established practice rather than unfamiliar territory.
03
EHR and Clinical Systems Depth
Our Voyant Health EHR and EMR work means EHR integration is handled by engineers who have built systems on both sides of the interface, not only consumed an API.
04
Sensitive Data Handling
Delivering CHIPSS for behavioral health required strict data segmentation and consent handling, experience that transfers directly to reproductive records and stored material directives.
05
US-Based Delivery Teams
Four US offices support overlapping working hours, on-site discovery in the laboratory, and direct engineer access, shortening stakeholder review cycles on regulated builds.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment without a long remediation phase.
Pricing
AI reproductive medicine pricing depends on scope, imaging data availability, integration surface, and regulatory pathway. A cryostorage tracking module costs considerably less than an embryo assessment model requiring annotation, validation, and a regulatory submission. We price after discovery, because imaging platform export capability and EMR structure vary widely between clinics and drive a large share of total effort. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown so components can be approved or deferred. Cloud infrastructure, imaging platform interface fees, and third-party licensing are separate from engineering cost and itemized clearly.
MVP or Single Module
An MVP covering one capability such as cryostorage tracking or witness logging typically runs $40,000 to $80,000, validating value before broader commitment.
Full Platform Build
A full platform with imaging integration, laboratory tooling, EMR interfaces, patient portal, and reporting typically falls between $80,000 and $200,000 depending on validation depth.
Enterprise Deployment
Enterprise engagements covering multi-site rollout, custom model development, held-out validation, and regulatory documentation start at $200,000 and scale with laboratory count.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and regulatory assessment. It is deliberately separable so you can evaluate our work first.
Cost Drivers to Expect
Annotation volume, imaging platform access, validation requirements, and SaMD documentation are the largest variables, each identified during discovery for realistic budget planning.
Ongoing Support Costs
Post-launch model monitoring, revalidation cycles, and support are quoted separately as a retainer sized to your laboratory footprint and quality review cadence.
Get Started
If you are evaluating AI reproductive medicine tooling for embryology assessment support, cryostorage traceability, cycle workflow, or outcome reporting, the fastest next step is a discovery call with our clinical engineering team. We will review your imaging platform, EMR structure, and intended use, then return an itemized, fixed-scope estimate with a clear regulatory assessment. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Fertility practices evaluating AI reproductive medicine software consistently raise three concerns: whether software selects embryos, what regulatory obligations the intended use creates, and whether models developed elsewhere will perform in their laboratory. The answers below reflect how we scope and deliver these projects in practice. If your situation involves a specific time-lapse platform, multi-site laboratory operations, or an intended use likely to require FDA submission, the specifics matter more than any general answer.
No. Every tool we build functions as clinical decision support. Models propose morphology scores and rankings for embryologist review, and the embryologist and reproductive endocrinologist make every selection, transfer, and cryopreservation decision. The software does not select embryos or set protocols in any configuration we build, and we make no claims about outcomes.
Often not without adaptation. Culture media, incubator conditions, imaging hardware, and patient population all affect model behavior, and published performance rarely transfers directly. We validate against your held-out data and report results honestly, including cases where performance does not justify clinical deployment.
It depends on intended use. Software influencing embryo selection may meet the definition of Software as a Medical Device and require a regulatory pathway, while laboratory documentation and inventory tooling generally does not. We assess classification during discovery and build the design controls and validation documentation your pathway requires.
An MVP or single module runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments with multi-site rollout and regulatory documentation start at $200,000. Discovery produces an itemized, fixed-scope estimate, with infrastructure and third-party licensing quoted separately from engineering.
Often yes, depending on manufacturer and system generation. Export capability varies considerably, and some platforms restrict access to image data or expose it only in proprietary formats. We verify what your specific equipment supports during discovery rather than assuming a level of access that may not exist.
Consent is built as a versioned data model tracking directives, expiry, and disposition instructions across long retention periods, with full audit history. Staff verification remains required for any disposition action. Software maintains the record and surfaces status rather than acting on directives automatically.